share_log
Moomoo 24/7 ·  Apr 24 08:02
ScPharmaceuticals Inc - Anticipates Topline Data in Q3 2024, Followed by a Supplemental New Drug Application (Snda) by Year-End 2024, IF Successful
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment